Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder

被引:0
|
作者
Glick, I [1 ]
Marder, SR [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:484 / 484
页数:1
相关论文
共 50 条
  • [1] Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder
    Glick, ID
    Marder, SR
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S162 - S162
  • [2] Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder
    Glick, ID
    Marder, SR
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (05) : 638 - 641
  • [3] The long-term benefit of risperidone versus haloperidol for affective symptoms in schizophrenia and schizoaffective disorder
    Myers, J
    Mahmoud, R
    Keith, SJ
    Csernansky, JG
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 240 - 240
  • [4] Olanzapine versus haloperidol in the treatment of schizoaffective disorder - Acute and long-term therapy
    Tran, PV
    Tollefson, GD
    Sanger, TM
    Lu, YL
    Berg, PH
    Beasley, CM
    BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 : 15 - 22
  • [5] Haloperidol versus atypical antipsychotics in the long-term treatment of schizophrenia
    Altamura, A. C.
    Buoli, M.
    Mauri, M. C.
    Dell'Osso, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S466 - S466
  • [6] Improved Treatment Outcome with Haloperidol Decanoate and Amantadine in an Adolescent with Schizoaffective Disorder
    Zaydlin, Michelle
    Bernal, Julia A.
    Bez, Yasin
    Coffey, Barbara J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (08) : 337 - 341
  • [7] HALOPERIDOL DECANOATE AND FLUPENTIXOL DECANOATE IN SCHIZOPHRENIA - A LONG-TERM DOUBLE-BLIND CROSSOVER COMPARISON
    EBERHARD, G
    HELLBOM, E
    ACTA PSYCHIATRICA SCANDINAVICA, 1986, 74 (03) : 255 - 262
  • [8] Bone density in chronic schizophrenia and schizoaffective disorder with long-term antipsychotic treatment
    Lee, T. Y.
    Chung, M. Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 99 - 99
  • [9] SAFETY AND EFFICACY OF LONG-TERM ASENAPINE VERSUS OLANZAPINE IN SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER PATIENTS
    Schoemaker, J.
    Naber, D.
    Jansen, W.
    Panagides, J.
    Emsley, R.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [10] Safety and efficacy of long-term asenapine versus olanzapine in schizophrenia or schizoaffective disorder patients
    Schoemaker, J.
    Stet, L.
    Naber, D.
    Panagides, J.
    Emsley, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 238 - 238